SCHEMBL3984126

SCHEMBL3984126

CC1(C)C2CC1C1C(OC(=O)O)C1(C)C2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.31
SLC1A2 P43004 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983194 0.75 UGT2B7 (0.36) APLNRSLC1A2
SCHEMBL2978406 0.70 RET (0.35)
SCHEMBL3981828 0.69 APLNR (0.32) APLNR
SCHEMBL3990125 0.69 APLNR (0.32) APLNR
SCHEMBL3980471 0.68 SCN1A (0.32)
SCHEMBL3986315 0.68 ALDH1A1 (0.31)
SCHEMBL3981527 0.68 LMNA (0.43)
SCHEMBL11097199 0.66 APLNR (0.36) APLNR
SCHEMBL10342515 0.66 APLNR (0.36) APLNR
SCHEMBL1971032 0.64 CYP19A1 (0.37) SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562575-B1 FUSED CYCLOALKYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF I.A. EPILEPSY ABBOTT LAB (US) 2009-05-20 EP claimed